InvestorsHub Logo
Followers 1
Posts 140
Boards Moderated 0
Alias Born 01/26/2017

Re: None

Thursday, 05/31/2018 2:26:25 PM

Thursday, May 31, 2018 2:26:25 PM

Post# of 16885
while it appears to be good news that Brawburn abandoned Probuphine ... the outlook is not clear in terms of commercial viability in TTNP's hands... in reviewing Braeburn's old S1 which lists some of the potential risks I have lots of questions on sourcing the EVA and the purchase of the buprenorphine from Teva .. + what is the status of the post approval trials requested from FDA... what about pain... on and on and on.... TTNP is not usually forthcoming w/information which may clarify a path forward for investors ... my hope continues to be that a larger competitor buys them out... on my short list would be: INVVY, ALKS, TEVA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News